Worth reading
59In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
28.1
% (year-on-year change in operating income)Wording
Conditional
How definitive the wording is.Results for this period
Third quarter1 January 2026 to 30 September 2026ConsolidatedIFRSNet Sales1,319,305¥ millionYear on year +7.1%Progress 73.3%
Operating profit146,539¥ millionYear on year +28.1%Progress 77.1%
Ordinary income148,664¥ millionYear on year +24.5%Progress 77.0%
Net income attributable to owners of the parent105,051¥ millionYear on year +24.0%Progress 77.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥116.12
Financial position at period-end
Total assets1,867,105¥ million
of which net assets 1,132,207 ¥ millionEquity ratio 59.1%vs. prior year-end +2.4pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+103,035
Investment-22,628
Financials-90,615
Net change-10,208
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥316,283 million
Segment revenueHygiene and Living Care Business ¥416,354 million (YoY +4.6%), Health and Beauty Care Business ¥341,696 million (YoY +6.2%), Cosmetics Business ¥199,433 million (YoY +10.1%), Business Connected Business ¥29,248 million (YoY +4.6%), Chemicals Business ¥332,574 million (YoY +9.5%)
Segment profitHygiene and Living Care Business ¥63,849 million, Health and Beauty Care Business ¥32,318 million, Cosmetics Business ¥9,785 million, Business Connected Business ¥1,805 million, Chemicals Business ¥26,985 million
Regional sales¥7,308 hundred million (YoY +5.1%), ¥2,691 hundred million (YoY +10.8%), ¥1,688 hundred million (YoY +9.5%), ¥1,506 hundred million (YoY +7.9%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥1,800,000 million (YoY +6.6%)
Operating profit¥190,000 million (YoY +16.2%)
Ordinary income¥193,000 million (YoY +13.6%)
Net income¥135,000 million (YoY +12.4%)
Revision to Earnings ForecastNo revision
Annual Dividend Forecast¥154 per share (excluding stock split) → ¥156 per share (excluding stock split)（+1.3%）
Factors Behind Changes in Business Performance
The global consumer care business expanded both in Japan and overseas, and profitability in the chemicals business improved. Contributions came from proposals for high-value-added products, price revisions, increased sales volumes, improved margins centered on oil and fat products, and expanded sales of high-value-added products in the electronic materials field. In the first quarter, the company also recorded a ¥11.5 billion gain on the sale of land.
Disclosure regarding the going concern assumption
No applicable matters.
Change in accounting policy
基準改正に伴う変更 Noneそれ以外の変更 Yes見積りの変更 None修正再表示 Yes (comparative information restated retrospectively in connection with the retrospective application of IFRS 18)
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Breakdown of extraordinary income (loss)Extraordinary Gains and Losses Not disclosed / Related non-recurring items ¥11,500 million
Depreciation and amortization¥67,522 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person For securities analysts and institutional investors
Issued Shares at Period-End907,200,000 shares
Treasury Shares at Period-End2,443,731 shares
| Item | Details |
|---|---|
| Fiscal Period Classification | Third quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026 to 30 September 2026 |
| Net Sales | ¥1,319,305 million (YoY +7.1%) |
| Operating profit | ¥146,539 million (YoY +28.1%) |
| Ordinary income | ¥148,664 million (YoY +24.5%) |
| Profit attributable to owners of the parent | ¥105,051 million (YoY +24.0%) |
| Net income per share | ¥116.12 |
| Equity ratio | End of the current fiscal period 59.1% / End of previous period 56.7% |
| Total assets | ¥1,867,105 million |
| Net assets | ¥1,132,207 million |
| Cash flows from operating activities | ¥103,035 million |
| Cash flows from investing activities | ¥-22,628 million |
| Cash flows from financing activities | ¥-90,615 million |
| Cash and cash equivalents at end of period | ¥316,283 million |
| Full-year earnings forecast | Net Sales ¥1,800,000 million (YoY +6.6%) / Operating profit ¥190,000 million (YoY +16.2%) / Ordinary income ¥193,000 million (YoY +13.6%) / Net income ¥135,000 million (YoY +12.4%) |
| Revision to Earnings Forecast | No revision |
| Annual Dividend Forecast | ¥154 per share (excluding stock split) → ¥156 per share (excluding stock split)（+1.3%） |
| Segment revenue | Hygiene and Living Care Business ¥416,354 million (YoY +4.6%), Health and Beauty Care Business ¥341,696 million (YoY +6.2%), Cosmetics Business ¥199,433 million (YoY +10.1%), Business Connected Business ¥29,248 million (YoY +4.6%), Chemicals Business ¥332,574 million (YoY +9.5%) |
| Segment profit | Hygiene and Living Care Business ¥63,849 million, Health and Beauty Care Business ¥32,318 million, Cosmetics Business ¥9,785 million, Business Connected Business ¥1,805 million, Chemicals Business ¥26,985 million |
| Regional sales | ¥7,308 hundred million (YoY +5.1%), ¥2,691 hundred million (YoY +10.8%), ¥1,688 hundred million (YoY +9.5%), ¥1,506 hundred million (YoY +7.9%) |
| Depreciation and amortization | ¥67,522 million |
| Breakdown of extraordinary income (loss) | Extraordinary Gains and Losses Not disclosed / Related non-recurring items ¥11,500 million |
| Disclosure regarding the going concern assumption | No applicable matters. |
| Change in accounting policy | Changes due to revisions to standards None / Other changes Yes / Change in accounting estimate None / Restatement Yes (comparative information restated retrospectively in connection with the retrospective application of IFRS 18) |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person For securities analysts and institutional investors |
| Issued Shares at Period-End | 907,200,000 shares |
| Treasury Shares at Period-End | 2,443,731 shares |
| Factors Behind Changes in Business Performance | The global consumer care business expanded both in Japan and overseas, and profitability in the chemicals business improved. Contributions came from proposals for high-value-added products, price revisions, increased sales volumes, improved margins centered on oil and fat products, and expanded sales of high-value-added products in the electronic materials field. In the first quarter, the company also recorded a ¥11.5 billion gain on the sale of land. |
Items this document does not state (6)
Operating MarginPayout ratioShareholder Return PolicyOrders received and order backlogImpairment lossMaterial subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The global consumer care business expanded both in Japan and overseas, while profitability in the chemicals business also improved. Contributions also came from proposals for high-value-added products, price revisions, increased sales volumes, and expanded sales of high-value-added products in the electronic materials field.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.